eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Eli Lilly and Company Limited

Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 11/02/2010
PIL Humulin I 100IU/ml suspension for injection in vial

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 28/04/2008 and displayed until 11/02/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 21/01/2008 and displayed until 28/04/2008
Reasons for adding or updating:
  • Addition of Marketing Authorisation Holder
  • Change to date of revision
Updated on 11/01/2008 and displayed until 21/01/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Pending awaiting re-submission
Updated on 26/04/2007 and displayed until 11/01/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Extra statutory information
  • Change to date of revision
Updated on 21/04/2006 and displayed until 26/04/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/11/2003 and displayed until 21/04/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   human insulin